MétaCan
Menu
Back to cohort
Record W4388495570 · doi:10.1038/s41408-023-00939-y

MRD negativity: considerations for older adults with multiple myeloma

2023· editorial· en· W4388495570 on OpenAlexafffund
Hira Mian, Tanya M. Wildes, Christopher P. Venner, Rafaël Fonseca

Bibliographic record

VenueBlood Cancer Journal · 2023
Typeeditorial
Languageen
FieldMedicine
TopicMultiple Myeloma Research and Treatments
Canadian institutionsUniversity of British ColumbiaMcMaster University
FundersNational Cancer InstituteHamilton Health Sciences FoundationHamilton Health Sciences
KeywordsMultiple myelomaMedicineNegativity effectInternal medicineOncologyGerontologyPsychologyDevelopmental psychology

Abstract

fetched live from OpenAlex

Minimal (or measurable) residual disease (MRD) negativity has emerged as one of the most important prognostic tools in multiple myeloma (MM) and is associated with significant improvements in progression-free survival (PFS) and overall survival [ 1 ]. Much of the focus on the role of MRD testing for prognosis and treatment selection has focused on younger, transplant eligible patients. However, MRD testing may be equally important among older transplant-ineligible patients with MM. We argue that MRD testing may prove to be a core component in the delivery of personalized and tailored treatment among older adults with MM. MRD testing may allow us to better balance both under-and over-treatment, a critical challenge in older adults with MM.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.004
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Editorial · Consensus signal: Editorial
Teacher disagreement score0.154
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.004
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0010.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.002
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.025
GPT teacher head0.328
Teacher spread0.303 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designNot applicable
Domainnot available
GenreEditorial

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations4
Published2023
Admission routes2
Has abstractyes

Explore more

Same venueBlood Cancer JournalSame topicMultiple Myeloma Research and TreatmentsFrench-language works237,207